E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 4
14 / 4Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Authorship Declaration

Original Research

Online Publishing Date:
23 / 02 / 2024

 


Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy

Ishu Kansal, Vishal Goel, Mohita Sangwaan.


Abstract
Background: Lack of vitamin D and estrogen both promote a spike in cytokine production, which increases osteoclastogenesis and causes bone resorption. Treatment with vitamin D strongly stimulates calcium resorption and decreases bone turnover. Vitamin D also decreases interleukin-6 (IL-6) levels, which further decreases the activity of osteoclast, which helps in regaining bone mineral density (BMD).

Aims and Objectives: To assess and evaluate the link between serum vitamin D levels, BMD, and IL-6 levels in osteoporotic pre- and post-menopausal women.

Materials and Methods: Three categories are formed among 36 female patients within the age group 30–55 years with osteoporosis: Group-1: Patients within age group 30–40 years; Group-2: Pre-menopausal patients within age group 40–55 years; and Group-3: Postmenopausal patients within age group 40–55 years. Serum 25-hydroxy vitamin D levels, IL-6 levels, and BMD scans were also done at baseline (day 0) before vitamin D supplementation and after 6 months of oral vitamin D therapy.

Results: The comparison between mean values of IL-6, serum 25-hydroxy vitamin D level, and BMD at baseline and at 24th week was highly significant for all three groups, which showed that the post-menopausal group, i.e., Group-3, had the lowest vitamin D levels and the lowest bone mass as compared to the pre-menopausal groups, i.e., Group-2 and Group-1. It was observed that mean values of 25-hydroxy vitamin D and BMD at the 24th week significantly increased and IL-6 values significantly decreased in all the women after 24 weeks of Vitamin D therapy.

Conclusion: There is a straight link between vitamin D and BMD in post-menopausal women and an opposite correlation between vitamin D and IL-6.

Key words: 25-Hydroxy Vitamin D; Interleukin-6; Bone Mineral Density; Osteoporosis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ishu Kansal
Articles by Vishal Goel
Articles by Mohita Sangwaan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Kansal I, Goel V, Sangwaan M. Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. Natl J Physiol Pharm Pharmacol. Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024

Web Style

Kansal I, Goel V, Sangwaan M. Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. https://www.njppp.com/?mno=177463 [Access: March 15, 2024]. doi:10.5455/njppp.2024.14.11536202308022024

AMA (American Medical Association) Style

Kansal I, Goel V, Sangwaan M. Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. Natl J Physiol Pharm Pharmacol. Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024


Vancouver/ICMJE Style

Kansal I, Goel V, Sangwaan M. Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. Natl J Physiol Pharm Pharmacol, [cited March 15, 2024]; Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024


Harvard Style

Kansal, I., Goel, . V. & Sangwaan, . M. (2024) Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. Natl J Physiol Pharm Pharmacol, Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024


Turabian Style

Kansal, Ishu, Vishal Goel, and Mohita Sangwaan. 2024. Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024


Chicago Style

Kansal, Ishu, Vishal Goel, and Mohita Sangwaan. "Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy." National Journal of Physiology, Pharmacy and Pharmacology Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024


MLA (The Modern Language Association) Style

Kansal, Ishu, Vishal Goel, and Mohita Sangwaan. "Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy." National Journal of Physiology, Pharmacy and Pharmacology Online First: 23 Feb, 2024. Web. 15 Mar 2024 doi:10.5455/njppp.2024.14.11536202308022024


APA (American Psychological Association) Style

Kansal, I., Goel, . V. & Sangwaan, . M. (2024) Association of serum vitamin D, IL-6 levels, and bone mineral density in pre- and post-menopausal women suffering from osteoporosis before and after vitamin D3 supplementation therapy. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 23 Feb, 2024. doi:10.5455/njppp.2024.14.11536202308022024


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Publisher

publishernjppp@gmail.com

 

Editorial query

editornjppp1@gmail.com

MOB - 8780040272